New Pill Choices Make Weight‑Loss Easier

"It is clear that people who start weight‑loss medicine want a cheaper and simpler option. Doctors say the oral version of Novo Nordisk’s Wegovy is popular because it does not need a needle, can be taken without special timing, and costs less than the injectable. The new Lilly pill, called Foundayo, is similar but can be taken at any time of day and may offer an extra choice for patients who dislike injections. Doctors note that many new users prefer the pill because they have never used an injectable before. Those who already tolerate injections are usually kept on their current medication unless they ask for a switch. The pills work by blocking the body’s hunger signals, and studies show they can reduce weight by about 12–14 percent. The injectable drug Zepbound, which has shown a larger weight loss of around 20 percent, is often chosen for patients with severe obesity.Cost remains the biggest concern. The monthly price of the oral pills starts at $149, while injectable options can cost $299 or more. Insurance coverage is limited, so patients often pay out of pocket. Doctors spend a lot of time explaining the financial side and helping patients choose the most affordable option. The new Lilly pill adds flexibility, especially because it can be taken with or without food. If its price matches that of the oral Wegovy, many patients may prefer it over the injection. Overall, the availability of pills is expanding access to weight‑loss treatment and giving both doctors and patients more options. The market for these drugs is expected to grow beyond $100 billion in the coming decade, reflecting a strong demand for convenient and cost‑effective solutions. "